FI971995A0 - Makrosykliset laktoniyhdisteet ja niiden tuotantomenetelmä - Google Patents

Makrosykliset laktoniyhdisteet ja niiden tuotantomenetelmä

Info

Publication number
FI971995A0
FI971995A0 FI971995A FI971995A FI971995A0 FI 971995 A0 FI971995 A0 FI 971995A0 FI 971995 A FI971995 A FI 971995A FI 971995 A FI971995 A FI 971995A FI 971995 A0 FI971995 A0 FI 971995A0
Authority
FI
Finland
Prior art keywords
macrocyclic lactone
preparation process
lactone compounds
compound
lactone compound
Prior art date
Application number
FI971995A
Other languages
English (en)
Swedish (sv)
Other versions
FI971995A (fi
Inventor
Hiroyuki Nishida
Yuji Yamauchi
Taisuke Inagaki
Yasuhiro Kojima
Nakao Kojima
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI971995A0 publication Critical patent/FI971995A0/fi
Publication of FI971995A publication Critical patent/FI971995A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI971995A 1994-11-10 1997-05-09 Makrosykliset laktoniyhdisteet ja niiden tuotantomenetelmä FI971995A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9401896 1994-11-10
PCT/IB1995/000870 WO1996015131A1 (en) 1994-11-10 1995-10-13 Macrocyclic lactone compounds and their production process

Publications (2)

Publication Number Publication Date
FI971995A0 true FI971995A0 (fi) 1997-05-09
FI971995A FI971995A (fi) 1997-05-09

Family

ID=1341416

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971995A FI971995A (fi) 1994-11-10 1997-05-09 Makrosykliset laktoniyhdisteet ja niiden tuotantomenetelmä

Country Status (12)

Country Link
US (2) US6001998A (fi)
EP (1) EP0854874B1 (fi)
JP (1) JP3061863B2 (fi)
AT (1) ATE239024T1 (fi)
CA (1) CA2204739C (fi)
DE (1) DE69530616T2 (fi)
DK (1) DK0854874T3 (fi)
ES (1) ES2194054T3 (fi)
FI (1) FI971995A (fi)
MX (1) MX9703484A (fi)
PT (1) PT854874E (fi)
WO (1) WO1996015131A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT854874E (pt) * 1994-11-10 2003-07-31 Pfizer Compostos de lactona macrociclica e seu processo de producao
US20040235889A1 (en) * 2001-05-02 2004-11-25 Miao-Kun Sun Carbonic anhydrase activator for enhancing learning and memory
US6551591B1 (en) 2001-09-07 2003-04-22 Essential Therapeutics, Inc. Antibiotics from microbispora
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
US20080004332A1 (en) * 2002-03-07 2008-01-03 Alkon Daniel L Methods for alzheimer's disease treatment and cognitive enhancement
US20050065205A1 (en) * 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
US7709632B2 (en) * 2004-02-17 2010-05-04 Johnson Thomas E Methods, compositions, and apparatuses for forming macrocyclic compounds
TW200538181A (en) * 2004-05-18 2005-12-01 Brni Neurosciences Inst Treatment of depressive disorders
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
CA2598805A1 (en) * 2005-02-24 2006-08-31 Biocern, Inc. Sperm cell separation methods and compositions
WO2006119211A2 (en) * 2005-05-02 2006-11-09 Genaera Corporation Methods and compositions for treating ocular disorders
WO2007016202A1 (en) 2005-07-29 2007-02-08 Blanchette Rockefeller Neurosciences Institute Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory
CA2659242C (en) 2006-07-28 2015-08-11 Blanchette Rockefeller Neurosciences Institute Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory
NZ575829A (en) * 2006-08-30 2012-04-27 Biocern Inc Sperm cell separation methods and compositions containing aptamers or nucleic acid sequences for use therein
EP2702993B1 (en) * 2006-09-13 2017-12-06 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
US8088789B2 (en) 2006-09-13 2012-01-03 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
US10695327B2 (en) 2006-09-13 2020-06-30 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
CA2873179A1 (en) 2007-02-09 2008-08-21 Blanchette Rockefeller Neurosciences Institute Use of bryostatins and neristatins in the treatment of cognitive impairment due to head trauma
CA2864550C (en) 2007-02-09 2018-07-10 Blanchette Rockefeller Neurosciences Institute Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
JP5726171B2 (ja) * 2009-05-01 2015-05-27 グリコミメティックス インコーポレイテッド Ｅ−セレクチンおよびｃｘｃｒ４ケモカイン受容体のヘテロ二官能性阻害剤
EP3141246A1 (en) * 2009-08-31 2017-03-15 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
WO2012006516A2 (en) 2010-07-08 2012-01-12 Alkon Daniel L Dag-type and indirect protein kinase c activators and anticoagulant for the treatment of stroke
JP6062362B2 (ja) 2010-08-19 2017-01-18 ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート Ｐｋｃ活性化剤を使用した、異常な樹状突起棘に関連した認知障害の治療
JP6422778B2 (ja) 2011-11-13 2018-11-14 ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート Ｐｋｃアクチベーターおよびその組合せ
CA2985625A1 (en) 2015-05-11 2016-11-17 Alkon, Daniel L. Treatment of neurodegenerative conditions using pkc activators after determining the presence of the apoe4 allele
RU2629653C1 (ru) * 2016-03-21 2017-08-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "Юго-Западный государственный университет " (ЮЗГУ) Мостовой измеритель параметров двухполюсников
CN107827803A (zh) * 2017-11-28 2018-03-23 绍兴厚普生物科技有限责任公司 一种从发酵液中提取l‑羟脯氨酸的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6903238A (fi) * 1968-03-04 1969-09-08
US5091389A (en) * 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
US5674732A (en) * 1992-04-27 1997-10-07 Pfizer Inc. Rapamycin producer
CA2106034A1 (en) * 1992-09-24 1994-03-25 Ralph J. Russo 21-norrapamycin
PT854874E (pt) * 1994-11-10 2003-07-31 Pfizer Compostos de lactona macrociclica e seu processo de producao

Also Published As

Publication number Publication date
EP0854874A1 (en) 1998-07-29
MX9703484A (es) 1997-08-30
JPH11507907A (ja) 1999-07-13
JP3061863B2 (ja) 2000-07-10
DK0854874T3 (da) 2003-06-02
PT854874E (pt) 2003-07-31
ES2194054T3 (es) 2003-11-16
DE69530616T2 (de) 2004-04-01
FI971995A (fi) 1997-05-09
ATE239024T1 (de) 2003-05-15
EP0854874B1 (en) 2003-05-02
DE69530616D1 (de) 2003-06-05
US6001998A (en) 1999-12-14
WO1996015131A1 (en) 1996-05-23
CA2204739C (en) 2000-04-04
US6187568B1 (en) 2001-02-13

Similar Documents

Publication Publication Date Title
FI971995A (fi) Makrosykliset laktoniyhdisteet ja niiden tuotantomenetelmä
BG100951A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
AU7116691A (en) Process for the preparation of oxetanones
AU5468194A (en) Compounds useful as sweetening agents and process for their preparation
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
ATE231850T1 (de) Isochroman verbindungen und verfahren zu deren produktion
EA199901016A1 (ru) 9-оксим-производные эритромицина
ZA951227B (en) Camptothecin derivatives and process for their preparation
ATE475653T1 (de) Verfahren zur herstellung von valsartan
MY145819A (en) Process and intermediates useful in the preparation of pharmaceutical compounds as fulvestrant
NZ308518A (en) Antibacterial cephalosporins
NO974320L (no) Fucopeptider
AU1306795A (en) Anticonvulsant pseudofructopyranose sulfamates
CA2019799A1 (en) Fucosidase inhibitor
Naruse et al. Aspochalasin E, a new antibiotic isolated from a fungus
DE3672361D1 (de) Ein neues ansamycin-antibiotikum, ein mikrobielles verfahren zu seiner herstellung und seine verwendung als arzneimittel.
MX9709494A (es) Compuestos peptidicos ciclicos, procedimiento para su produccion, composiciones que los contienen y uso de los mismos.
AP9801235A0 (en) Erythromycin derivatives.
Berova et al. Malonofungin: An antifungal aminomalonic acid from Phaeoramularia fusimaculans
AP2002002494A0 (en) Hygromycin derivatives.
IL116646A (en) Antifungal fusacandins, process for their preparation, pharmaceutical compositions containing them and uses thereof
SK11202003A3 (sk) Použitie tiolutín-dioxidu a jeho derivátov na prípravu liečiva, spôsob jeho prípravy pomocou mikroorganizmu a mikroorganizmus Nocardiopsis species ST 100692, DSM 13834
AU9057098A (en) Dithiolopyrrolones and their corresponding monoxides and dioxides as antineoplastic agents
YU57900A (sh) Sinteza karbamatno ketolidnih antibiotika
CA2230303A1 (en) Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin

Legal Events

Date Code Title Description
MA Patent expired